Clinical Trial Update: Safety and Efficacy of A-007 Topical Gel in the Treatment of High-Grade Squamous Intraepithelial Lesions (HSIL) of the Cervix [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating safety and efficacy of A-007 topical gel for high-grade cervical intraepithelial lesions; the study is completed and results w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Intraepithelial Neoplasia
• Uterine Cervical Dysplasia

Drugs mentioned

• A-007 Topical Gel

Snippet

Sponsor: Tigris Pharmaceuticals | Conditions: Cervical Intraepithelial Neoplasia, Uterine Cervical Dysplasia | Phase 2 | Status: COMPLETED | Results posted: 2010-10-11